Review of SMARCA4 (BRG1)-deficient Carcinomas Following a Malignant Pleural Effusion Specimen Confounded by Reduced Claudin-4 Expression
The eJournal is an online pathology journal club that reviews current articles from a peer-reviewed cytopathology Journal.
Participants will be able to review the journal article, commentary and webinar from the contributing author. This is a great self-assessment, teaching and continuing education tool.
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
- Cytomorphology of SMARCA4 deficient malignancies
- Ancillary testing for diagnosis of SMARCA4 deficient malignancies
- Understand the pathways for carcinogenesis in SMARCA4 mutated/deficient tumors
- Role of Claudin-4 expression in SMARCA4 deficient carcinomas
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. Click here for a complete list.
Saloni Walia, MD
University of Southern California
Los Angeles, California
The presenter has no conflicts of interest or financial relationships to disclose.
ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Continuing Certification (CC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Continuing Certification (CC) process. Earn up to 1.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 1.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 1 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the presentation date.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 1.00 CMLE
- 1.00 Florida Credits
- 1.00 MOC II
- 1.00 Participant